Organic Acid Disorders

Isovaleric Acidemia (IVA)

background

background

Isovaleric acidemia results from a defect in the metabolism of the amino acid, leucine. The first patient with isovaleric acidemia was described in 1966 and the deficiency of isovaleryl-CoA dehydrogenase activity was found a few years later. Isovaleryl-CoA dehydrogenase functions in the inner mitochondrial matrix. The gene is located on chromosome 15. IVA is estimated to occur in less than 1 in 100,000 live births.

clinical

clinical

Isovaleryl-CoA dehydrogenase deficiency has two general presentations. The first occurs within days or weeks of life as an acute, overwhelming illness with vomiting and ketoacidosis progressing to lethargy, coma and death in greater than 50% of the patients. Other laboratory findings include variable hyperammonemia, hypocalcemia, neutropenia, thrombocytopenia, and pancytopenia. A second cohort has onset later in the first year of life or after. These patients develop chronic, intermittent illnesses brought on by infection or a large protein intake. Laboratory findings will be as noted above, but perhaps not so severe. Both groups are susceptible to infection. The patient commonly has a distinctive odor of “sweaty feet” during an illness because of the volatile isovaleric acid that accumulates.

testing

testing

treatment

treatment

Treatment of patients with isovaleric acidemia involves reducing protein intake, particularly the branched-chain amino acid leucine. During an acute episode, aggressive use of glucose and electrolytes is necessary. Glycine supplementation has proven beneficial because this amino acid is conjugated to isovalerate, forming the less harmful isovalerylglycine. Carnitine treatment is similarly effective. Strict dietary control and aggressive treatment have resulted in normal development in some patients. However, many patients with isovaleric acidemia show neurologic abnormalities from acute illness.

Because the diagnosis and therapy of isovaleric acidemia is complex, the pediatrician is advised to manage the patient in close collaboration with a consulting pediatric metabolic disease specialist and dietician. It is recommended that parents travel with a letter of treatment guidelines from the patient’s physician.

inheritance

inheritance

This disorder most often follows an autosomal recessive inheritance pattern. With recessive disorders affected patients usually have two copies of a disease gene (or mutation) in order to show symptoms. People with only one copy of the disease gene (called carriers) generally do not show signs or symptoms of the condition but can pass the disease gene to their children. When both parents are carriers of the disease gene for a particular disorder, there is a 25% chance with each pregnancy that they will have a child affected with the disorder.

Source: Newborn Screening Today (2011), PerkinElmer Inc., Waltham MA
This website stores cookies on your computer. These cookies are used to improve our website and provide more personalised services to you.
Close

Cookies

To make this site work properly, we sometimes place small data files called cookies on your device. Most big websites do this too.

1. What are cookies?

A cookie is a small text file that a website saves on your computer or mobile device when you visit the site. It enables the website to remember your actions and preferences (such as login, language, font size and other display preferences) over a period of time, so you don’t have to keep re-entering them whenever you come back to the site or browse from one page to another.

2. How do we use cookies?

A number of our pages use cookies to remember your actions and preferences (such as login, language, font size and other display preferences.)

Also, some videos embedded in our pages use a cookie to anonymously gather statistics on how you got there and what videos you visited.

Enabling these cookies is not strictly necessary for the website to work but it will provide you with a better browsing experience. You can delete or block these cookies, but if you do that some features of this site may not work as intended.

The cookie-related information is not used to identify you personally and the pattern data is fully under our control. These cookies are not used for any purpose other than those described here.

3. How to control cookies

You can control and/or delete cookies as you wish – for details, see aboutcookies.org. You can delete all cookies that are already on your computer and you can set most browsers to prevent them from being placed. If you do this, however, you may have to manually adjust some preferences every time you visit a site and some services and functionalities may not work.

Close